Profile
Stefan Rehnmark is the founder of Axcentua Pharmaceuticals AB, which was founded in 2007.
He held the title of Chief Executive & Scientific Officer at the company.
Dr. Rehnmark is also the founder of Noviga Research AB. Dr. Rehnmark's current job(s) include being a Director at LIDDS AB since 2024 and serving as the Chief Scientific Officer at Gabather AB. Dr. Rehnmark's former job was as an Assistant Professor at the University of Stockholm from 1994 to 2000.
Dr. Rehnmark obtained a doctorate degree from the University of Stockholm.
Stefan Rehnmark active positions
| Companies | Position | Start |
|---|---|---|
| GABATHER AB | Chief Tech/Sci/R&D Officer | 31/12/2017 |
| LIDDS AB | Director/Board Member | 26/05/2024 |
Former positions of Stefan Rehnmark
| Companies | Position | End |
|---|---|---|
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/12/1997 |
Noviga Research AB | Founder | - |
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs for pancreatic cancer | Chief Executive Officer | - |
Training of Stefan Rehnmark
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs for pancreatic cancer | Health Technology |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Gabather AB
Gabather AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops mental health drugs | Health Technology |
Noviga Research AB |
- Stock Market
- Insiders
- Stefan Rehnmark
















